These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 8667045)

  • 1. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
    J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
    Piert M; Koeppe RA; Giordani B; Minoshima S; Kuhl DE
    J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished glucose transport in Alzheimer's disease: dynamic PET studies.
    Jagust WJ; Seab JP; Huesman RH; Valk PE; Mathis CA; Reed BR; Coxson PG; Budinger TF
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):323-30. PubMed ID: 1997504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional cerebral glucose transport and utilization in Alzheimer's disease.
    Friedland RP; Jagust WJ; Huesman RH; Koss E; Knittel B; Mathis CA; Ober BA; Mazoyer BM; Budinger TF
    Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
    Kuwabara H; Gjedde A
    J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
    Ishii K; Sasaki M; Kitagaki H; Yamaji S; Sakamoto S; Matsuda K; Mori E
    J Nucl Med; 1997 Jun; 38(6):925-8. PubMed ID: 9189143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
    Fukuyama H; Ogawa M; Yamauchi H; Yamaguchi S; Kimura J; Yonekura Y; Konishi J
    J Nucl Med; 1994 Jan; 35(1):1-6. PubMed ID: 8271029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
    Minoshima S; Frey KA; Koeppe RA; Foster NL; Kuhl DE
    J Nucl Med; 1995 Jul; 36(7):1238-48. PubMed ID: 7790950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic [18F]fluorodeoxyglucose positron emission tomography and hypometabolic zones in seizures: reduced capillary influx.
    Cornford EM; Gee MN; Swartz BE; Mandelkern MA; Blahd WH; Landaw EM; Delgado-Escueta AV
    Ann Neurol; 1998 Jun; 43(6):801-8. PubMed ID: 9629850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease.
    Groom GN; Junck L; Foster NL; Frey KA; Kuhl DE
    J Nucl Med; 1995 Dec; 36(12):2207-10. PubMed ID: 8523106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.
    Dhawan V; Moeller JR; Strother SC; Evans AC; Rottenberg DA
    J Nucl Med; 1989 Sep; 30(9):1483-8. PubMed ID: 2788721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
    CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebral glucose metabolism in dementia (PET-FDG study)].
    Hatazawa J; Itoh M; Matsuzawa T
    Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
    Fukuyama H; Harada K; Yamauchi H; Miyoshi T; Yamaguchi S; Kimura J; Kameyama M; Senda M; Yonekura Y; Konishi J
    J Neurol Sci; 1991 Dec; 106(2):128-34. PubMed ID: 1802960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
    Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method.
    Kuhl DE; Metter EJ; Riege WH; Phelps ME
    J Cereb Blood Flow Metab; 1982; 2(2):163-71. PubMed ID: 6978885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.